File photograph. / SUR

The Junta will request the 'Covid passport' for nightlife if the region's top court endorses it for hospitals and nursing homes

This Wednesday the regional government will seek the TSJA’s endorsement to require the mandatory presentation of a coronavirus vaccination certificate to access residences for the elderly and hospitals

Héctor Barbotta

The Junta de Andalucía plans to request the endorsement of the region’s top court, the TSJA, to implement the Covid passport - the obligation to present a vaccination certificate - to allow access to nightlife venues.

But before that, this Wednesday (1 December), the Junta will present its case before the Granada chamber of the Superior Court of Justice of Andalucía to make the presentation of this certificate mandatory to access hospitals and residences for the elderly in the region.

If the Junta obtains the endorsement of the TSJA to implement this measure, it will immediately request a similar measure for nightlife venues.

Regional government ministers consider that it makes no sense to try to take that second step if judicial permission is not first obtained to implement restrictions to access to hospitals and nursing homes.

In the last ten days the vaccination process has accelerated in the region and a total of 20,000 people in Andalucía who had not been jabbed visited one of the Junta’s vaccination centres to receive a dose of a coronavirus vaccine.

Intensive care cases

There is still 8 per cent of the target population - over 12 years of age – that remain un-jabbed in the region. They constitute the majority of the patients who occupy intensive care units in Andalusian hospitals with serious Covid cases, the Junta’s spokesperson, Elías Bendodo, warned this Tuesday.

Bendodo explained that the evolution of the sixth wave of the disease is not translating into hospital admissions in the region thanks to the high percentage of the vaccinated population. He also announced that as soon as it has the doses, the Junta will begin the vaccination of minors between the ages of 5 and 11 years, and will extend the administration of the third dose to the rest of the population.